Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05016219

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Phase 2 - The Use of Rhythmic Light Therapy to Entrain Gamma Oscillations and the Circadian System in Patients With Alzheimer's Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

Participants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light \[RL\]); (2) a placebo light with a random flicker (placebo condition for rhythmic light); (3) a light source that will stimulate the circadian system and provides a 40 Hz flicker (RL); or (4) a light source that will stimulate the circadian system and provides a random flicker (placebo condition for rhythmic light). Following a baseline week, participants will experience his/her assigned lighting condition for two hours in the morning for 8 weeks. After a 4-week washout period, a final round of assessments will be obtained. Study assessments (except for the Pittsburgh Sleep Quality Index and Montreal Cognitive Assessment) will be collected at the end of each week, for a total of 8 assessments.

Detailed description

The tailored lighting intervention used to promote circadian entrainment will provide high circadian stimulation during the day produced by narrowband blue light peaking at 470 nanometers (nm). A comparison lighting intervention (i.e., placebo lighting), a narrowband red light peaking at 630 nm, will be used as a control. Both the red and the blue light devices will also provide either the 40 hertz (Hz) flicker (RL) or the random flicker (placebo RL). For the random flicker (placebo RL), the duty cycle will be delivered with a random interval determined by a Poisson process with an average interval of 40 hertz (Hz).

Conditions

Interventions

TypeNameDescription
DEVICECircadian-Effective LightNarrowband blue light
DEVICERhythmic Light40 hertz (Hz) flicker
DEVICEPlacebo LightNarrowband red light
DEVICEPlacebo Rhythmic LightRandom flicker for placebo rhythmic effect

Timeline

Start date
2023-08-22
Primary completion
2026-07-31
Completion
2027-07-31
First posted
2021-08-23
Last updated
2025-06-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05016219. Inclusion in this directory is not an endorsement.